Article Details
Retrieved on: 2019-05-09 23:48:02
Tags for this article:
Click the tags to see associated articles and topics
Excerpt
<div>Finally, <b>Acadian Asset Management</b> LLC acquired a new position in Adaptimmune Therapeutics in the 4th quarter valued at $219,000. 65.96% of the ...</div>
Article found on:
This article is found inside other hiswai user's workspaces. To start your own collection, sign up for free.
Sign UpAlready have an account? Log in here